IL17A and metabolic dysfunction-associated steatotic liver disease: In conclusion, this study established a comorbidity model to explain the underlying mechanism of IBD combined with NAFLD, identified the cytokine IL-17-mediated chemokine-related pathway as the core pathway in the IBD combined with NAFLD comorbidity model, and found that miRNAs may also play a role in IBD with NAFLD.